Rapid risk assessment: Regional outbreak of New Delhi metallo-betalactamase-producing carbapenem-resistant Enterobacteriaceae, Italy, 2018–2019
A large outbreak of New Delhi metallo-beta-lactamase (NDM)-producing carbapenem-resistant Enterobacteriaceae (CRE) has been reported from the Tuscany region in Italy. Between November 2018 and May 2019, seven Tuscan hospitals notified a total of 350 cases.
ECDC country visit to Norway to discuss antimicrobial resistance issues
An ECDC country visit team conducted an assessment mission during the period 12–16 March 2018 to discuss antimicrobial resistance (AMR) issues in Norway. The overall objective of the mission was to provide an observation-based assessment of the situation in Norway regarding prevention and control of AMR through prudent use of antibiotics and infection control.
Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals - ECDC PPS validation protocol version 3.1.2.
This protocol version is an accompanying document to the ECDC protocol for the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals version 5.3.
Surveillance of antimicrobial resistance in Europe 2017
EARS-Net data for 2017 show that antimicrobial resistance remains a serious threat in Europe.
ECDC country visit to Malta to discuss antimicrobial resistance issues, 3-7 July 2017
The ECDC and the European Commission's Directorate-General for Health and Food Safety, at the invitation of the Maltese authorities, jointly carried out a country visit from 3 to 7 July 2017. The overall aim of the visit was to assist them in the further development and implementation of their national policies and strategies for tackling antimicrobial resistance based on a One Health perspective.
External quality assessment of laboratory performance – European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017
This report provides an analysis of the external quality assessment (EQA) performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2017.
Rapid risk assessment: Multidrug-resistant Staphylococcus epidermidis
This rapid risk assessment addresses the public health risk associated with a previously unrecognised international spread of near pandrug-resistant strains of S. epidermidis as a cause of infection in several countries including EU Member States.
ECDC country visit to Belgium to discuss antimicrobial resistance issues
An ECDC country visit team conducted an assessment mission on 20-24 November 2017 to discuss antimicrobial resistance (AMR) issues in Belgium with the overall objective to provide an observation-based assessment of the situation in Belgium regarding prevention and control of AMR through prudent use of antibiotics and infection control.
Rapid risk assessment: Carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 in travellers previously hospitalised in Gran Canaria, Spain
This rapid risk assessment evaluates the risk of transmission and further spread of OXA-48-producing Klebsiella pneumonia e ST392 from travellers having sought medical care in Gran Canaria to healthcare facilities in their country of origin in the EU/EEA.
Antimicrobial resistance (EARS-Net) - Annual Epidemiological Report for 2014
Over the last four years (2011 to 2014), the percentages of Klebsiella pneumonia e resistant to fluoroquinolones, third-generation cephalosporins and aminoglycosides, as well as combined resistance to all three antimicrobial groups, has increased significantly at the EU/EEA level.